Trial
NCT05601492
Adherence to Otezla
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
Amgen
Condition
Psoriasis
Intervention
Otezla - Standard Care
Why stopped
Terminated IRB approval 6/26/2024, study was never initiated or activated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29